Novel Ingredients in Infant Formula Market
完整報告名稱與涵蓋範圍
Novel Ingredients in Infant Formula Market, Share & Trends Analysis Report, By Ingredient Type (Human Milk Oligosaccharides (HMOs), Milk Fat Globule Membrane (MFGM), Synthetic/Bioengineered Proteins, Next-Gen Probiotics, Plant-Based Bioactives, Glycomacropeptides (GMPs), Exosomes and MicroRNAs), By Application (Standard Infant Formula, Follow-On Formula, Specialty Formula, Growing-Up Milk), By Region, and Segment Forecasts, 2025-2034
報告摘要
The global Novel Ingredients in Infant Formula Market is forecasted to progress at a compound annual growth rate of 8.7% throughout the 2025–2034 forecast period.
Novel Ingredients in Infant Formula encompasses substances that have recently been created or incorporated into infant formula to more closely resemble the composition of human breast milk and support the overall growth, devel. The sector has gained traction as organizations seek innovative approaches to address evolving industrial challenges.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the mounting emphasis on efficiency and sustainability within the industrial sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold pronounced shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Novel Ingredients in Infant Formula Market Snapshot
Chapter 4. Global Novel Ingredients in Infant Formula Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.9. Use/impact of AI on Novel Ingredients in Infant Formula Market Industry Trends
4.10. Global Novel Ingredients in Infant Formula Market Penetration & Growth Prospect Mapping (US$ Mn), 2021-2034
Chapter 5. Novel Ingredients in Infant Formula Market Segmentation 1: Ingredient Type, Estimates & Trend Analysis
5.1. Market Share Ingredient Type, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product Type:
5.2.1. Human Milk Oligosaccharides (HMOs)
5.2.2. Milk Fat Globule Membrane (MFGM)
5.2.3. Synthetic/Bioengineered Proteins
5.2.4. Next-Gen Probiotics
5.2.5. Plant-Based Bioactives
5.2.6. Glycomacropeptides (GMPs)
5.2.7. Exosomes and MicroRNAs
Chapter 6. Novel Ingredients in Infant Formula Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Standard Infant Formula
6.2.2. Follow-On Formula
6.2.3. Specialty Formula
6.2.4. Growing-Up Milk
Chapter 7. Novel Ingredients in Infant Formula Market Segmentation 3: By Source, Estimates & Trend Analysis
7.1. Market Share by Source, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Source:
7.2.1. Bioengineered
7.2.2. Plant-Based
7.2.3. Animal-Derived
Chapter 8. Novel Ingredients in Infant Formula Market Segmentation 5: Regional Estimates & Trend Analysis
8.1. Global Novel Ingredients in Infant Formula Market, Regional Snapshot 2024 & 2034
8.2. North America
8.2.1. North America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts Ingredient Type, 2021-2034
8.2.3. North America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.2.4. North America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
8.3. Europe
8.3.1. Europe Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts Ingredient Type, 2021-2034
8.3.3. Europe Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.3.4. Europe Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
8.4. Asia Pacific
8.4.1. Asia Pacific Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts Ingredient Type, 2021-2034
8.4.3. Asia Pacific Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.4.4. Asia Pacific Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
8.5. Latin America
8.5.1. Latin America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts Ingredient Type, 2021-2034
8.5.3. Latin America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.5.4. Latin America Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
8.6. Middle East & Africa
8.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts Ingredient Type, 2021-2034
8.6.3. Middle East & Africa Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
8.6.4. Middle East & Africa Novel Ingredients in Infant Formula Market Revenue (US$ Million) Estimates and Forecasts by Source, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. DSM
9.2.1.1. Business Overview
9.2.1.2. Key Product Type/Service Overview
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. Blue Diamond Growers, Inc
9.2.3. FrieslandCampina
9.2.4. Novonesis (Chr. Hansen + Novozymes)
9.2.5. DuPont (IFF Nutrition)
9.2.6. BASF
9.2.7. AAK
9.2.8. Glycosyn
9.2.9. Inbiose
9.2.10. Kyowa Hakko
9.2.11. Nestlé
9.2.12. Danone (Nutricia)
9.2.13. Abbott Nutrition
9.2.14. Reckitt (Mead Johnson)
9.2.15. Arla Foods
9.2.16. Fonterra
9.2.17. Helaina
9.2.18. Biomilq
9.2.19. 108LABS
9.2.20. Turtletree Labs
9.2.21. Else Nutrition
9.2.22. ByHeart
9.2.23. Sprout Organic
9.2.24. Conagen
9.2.25. Nature's One
9.2.26. Bactolife
9.2.27. Evonik
9.2.28. Glycotope
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們